In Brief: Beta Dermaceuticals
This article was originally published in The Rose Sheet
Executive Summary
Beta Dermaceuticals: Initiates Class III recall (no adverse health effects likely) for Beta-HC .25% hydrocortisone lotion via letter Aug. 20, according to FDA's Sept. 25 "Enforcement Report." San Antonio, Texas-based Beta Dermaceuticals initiated the nationwide recall of 1,189 bottles after an FDA analysis found the formulation to be subpotent. The firm estimated that at the start of the recall only 642 bottles of Beta-HC remained on the market...